Some young and middle aged people, barely sick with COVID-19, are dying from strokes
Washington Post article -- interesting -- strange how this virus isn't what it first appeared to be, and how crucial cardiovascular...
top of page
Please follow my twitter account @jsm2334 for more recent commentaries and threads on COVID-19 topics
Covid-19 Data Science
Finding the signal in the noise of Covid-19
Reporting and balanced evaluation of research results, data sets, applications and models, and commentaries related to Covid-19 and its underlying virus, SARS-Cov-2
Home: Welcome
Search
COVID-19 vaccine development update
An article in Nature Reviews drug discovery summarizes current vaccine developments -- 5 in phase 1 clinical trials already and many...
Clinical Characteristics, Comorbidities, and Outcomes Among Hospitalized NYC Patients with COVID-19
JAMA paper reporting characteristics of NYC hospital system infected — some key statistics: - 94% had comorbidities, most commonly high...
COVID-19 Models: Can they tell us what we want to know?
Nice article posted by my epidemiology colleague John H Holmes who has been trapped in Northern Italy during this crisis. Is a nice...
Not Enough COVID-19 Tests ... Yet Too Many COVID-19 Tests
Interest article from fivethirtyeight.com talking about our tricky situation with covid testing
Current NIH Guidelines for COVID-19 Treatment
Current NIH recommendations on Covid-19 Treatment: * No treatment shown to be safe and effective yet. * Remdesivir and HCQ/CQ said to...
Johns Hopkins Public Health Principles for a Phased Reopening During COVID-19: Guide for Governors
Guidelines from CenterforHealthSecurity.org: The contact tracing is most difficult part in the USA right now.
How Coronavirus kills.
Informative article from Science discussing the many ways this virus attacks the body. Really nasty virus and different from anything...
Article on "Swedish Model" by Project-Syndicate
Nice article on Project-Syndicate discussing Swedish strategy to covid that did not practice social distancing until much later and did...
1/3 of 200 blood samples in Chelsea show exposure to coronavirus
Article from Boston Globe: Not scientific study but 30% of these seemingly healthy people out in the streets in Chelsea showed antibodies...
Commentary by Derek Lowe at Science Translational Medicine on Small Molecule Clinical Data
Here is a blog in Science Translational Medicine that looks at available evidence for the three main antiviral treatment regimens being...
NIH Private-Public Partnerships Launched to Speed COVID-19 Vaccine and Treatment Options
Great private-partnership effort to try to coordinate the hundreds of civid-related research studies so we can most effectively and...
Media's Virus Messaging Shapes Public Compliance, Skepticism (RealClearPolitics)
Interesting article from my favorite balanced political website RealClearPolitics tracking the media's discussion of the virus, seeing as...
What Next with COVID-19?
Ok -- I can't any longer resist the temptation to say what I think about the next steps in this covid crisis ... these are my own...
Preliminary Results from Randomized Open Label Trial of HCQ
New paper on medrxiv yesterday reporting results from (open label) randomized study of Hydroxychloroquine (no Azithromycin) + standard of...
WHO Launches Global Meta-Trial of COVID-19
Science magazine describes international WHO clinical trial for covid-19. It randomizes between local standard of care, Remdisivir,...
Which Coronavirus statistics can we trust and which should we ignore?
Article in the Observer from two well-know statisticians, Sylvia Richardson and David Spiegelhalter, summarizing the trickiness of...
Diagram Showing How COVID-19 Attacks the Body
Very informative and accessible diagram showing how COVID-19 affects you
Asymptomatic and Mild Cases of COVID-19: potential concern
Article looking at immune response and possible immunity or not -- we still have a lot to learn!
Texas A&M pandemic expert: Coronavirus will have 5 stages: We're in stage 2
Great article from Houston Chronicle interviewing Gerald Parker, Texas A&M expert on pandemics with government experience, describing...
Home: Blog2
Home: Subscribe
Home: Contact
bottom of page